IOVA FY 2018 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

IOVAIovance Biotherapeutics, Inc.

$2B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$956,000

Operating Income

-$128M

Net Income

-$124M

EPS (Diluted)

$-1.27

Cash Flow

Operating Cash Flow

-$101M

Free Cash Flow

-$102M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$481M

Total Liabilities

$15M

Stockholders' Equity

$466M

Cash & Equivalents

$82M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$956,000	-$952,000	-0.4%
Operating Income	-$128M	-$93M	-38.1%
Net Income	-$124M	-$92M	-34.2%